secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nutex Health Inc. (NUTX)
CIK:        0001479681
Form:       8-K
Filed at:   2022-11-22T23:59:59+00:00
Accession:  0001607062-22-000733
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nutex Health reports Q3 net loss of $422.5M and $100M Lincoln Park equity facility
--------------------------------------------------------------------------------

- Q3 net revenue $28.4M, down ~76% YoY, including $29M reduction in accounts receivable estimate.
- Net loss attributable to Nutex $422.5M in Q3, driven by $408.5M non-cash goodwill impairment.
- Adjusted EBITDA loss of $15.7M in Q3; positive $18.5M for nine months ended September 30, 2022.
- Net cash from operations $46.1M for nine months; cash and equivalents $36.6M as of Sep 30.
- Entered $100M common stock purchase agreement with Lincoln Park Capital over 36 months, no warrants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479681/000160706222000733/0001607062-22-000733-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479681/000160706222000733/nutx111422form8k.htm
  HTML page:      https://secwatch.observer/filing/0001607062-22-000733

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer